Also in MUT-TP53 patients with stage I/II DLBCL, positive p65 nuclear expression was associated with significant poorer survival; in contrast, opposite trends were observed in MUT-TP53 patients with stage III/IV DLBCL (Fig. 1E). This evidence concerns the gene RELA and diffuse large B-cell lymphoma.